2026 Summer Intern Corporate Affairs at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Undergraduate student from an accredited university majoring in Journalism, Communications, English, or a related field; must remain enrolled through Fall 2026
  • GPA of 3.0 or higher (must be listed on the resume)
  • Authorized to work in the US both at the time of hire and for the duration of employment (no immigration or visa sponsorship available)
  • Strong professional writing and project management skills in areas such as Corporate/Executive Communications, Marketing/Advertising, Government Affairs, Research & Development, Issues Management, Analytics, Strategy & Business Operations, or Public/Media Relations
  • Experience developing targeted, compelling communications, managing projects and deadlines, and planning, coordinating, and executing events
  • Creative thinker with excellent attention to detail and strong storytelling abilities, including blogging, metrics, and reporting
  • Highly skilled in Microsoft Office Suite (Word, PowerPoint, Excel), Outlook, Teams, and social media platforms (LinkedIn, X/Twitter, Instagram, etc.)
  • Team player with exceptional writing skills

Responsibilities

  • Lead/participate in projects and/or communications planning process, including contributing to brainstorming and tactical planning
  • Support one of the teams (Issues Management, Strategy & Operations, Commercial, Research & Development, Government Affairs, Public Policy, Corporate Communications, Media Relations, Patient Advocacy) within CA with initiatives that successfully communicate brand and therapeutic area milestones, as well as support the science story
  • Support the enterprise measurement strategy to actively manage and optimize engagement communication performance across internal and external channels
  • Support key events and campaigns to increase employee engagement and drive our company brand and culture
  • Project management and administrative tasks as needed

Skills

Corporate Affairs
Internal Communications
External Communications
Engagement Strategy
Team Initiatives
Brand Awareness

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI